TBX3 behaves as a tumor suppressor or oncoprotein across cancer. However, TBX3 function remains undetermined in intrahepatic cholangiocarcinoma (iCCA), a deadly primary liver malignancy with few systemic treatment options. This study sought to investigate the impact of TBX3 on iCCA. We found that overexpression of TBX3 strongly inhibited human iCCA cell growth. In the Akt/FBXW7 Delta F mouse iCCA model, overexpression of Tbx3 reduced cholangiocarcinogenesis in vivo, while inducible genetic knockout of Tbx3 accelerated iCCA growth. RNA-seq identified MAD2L1 as a downregulated gene in TBX3-overexpressing cells, and ChIP confirmed that TBX3 binds to the MAD2L1 promoter. CRISPR-mediated knockdown of Mad2l1 significantly reduced the growth of two iCCA models in vivo. Finally, we found that TBX3 expression is upregulated in similar to 20% of human iCCA samples, and its high expression is associated with less proliferation and better survival. MAD2L1 expression is upregulated in most human iCCA samples and negatively correlated with TBX3 expression. Altogether, our findings suggest that overexpression of TBX3 suppresses CCA progression via repressing MAD2L1 expression.

Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma / Deng, Shanshan; Lu, Xinjun; Wang, Xue; Liang, Binyong; Xu, Hongwei; Yang, Doris; Cui, Guofei; Yonemura, Andrew; Paine, Honor; Zhou, Yi; Zhang, Yi; Simile, Maria Maddalena; Urigo, Francesco; Evert, Matthias; Calvisi, Diego F; Green, Benjamin L; Chen, Xin. - In: CELL DEATH & DISEASE. - ISSN 2041-4889. - 15:6(2024). [10.1038/s41419-024-06839-8]

Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma

Simile, Maria Maddalena;Urigo, Francesco;Calvisi, Diego F;
2024-01-01

Abstract

TBX3 behaves as a tumor suppressor or oncoprotein across cancer. However, TBX3 function remains undetermined in intrahepatic cholangiocarcinoma (iCCA), a deadly primary liver malignancy with few systemic treatment options. This study sought to investigate the impact of TBX3 on iCCA. We found that overexpression of TBX3 strongly inhibited human iCCA cell growth. In the Akt/FBXW7 Delta F mouse iCCA model, overexpression of Tbx3 reduced cholangiocarcinogenesis in vivo, while inducible genetic knockout of Tbx3 accelerated iCCA growth. RNA-seq identified MAD2L1 as a downregulated gene in TBX3-overexpressing cells, and ChIP confirmed that TBX3 binds to the MAD2L1 promoter. CRISPR-mediated knockdown of Mad2l1 significantly reduced the growth of two iCCA models in vivo. Finally, we found that TBX3 expression is upregulated in similar to 20% of human iCCA samples, and its high expression is associated with less proliferation and better survival. MAD2L1 expression is upregulated in most human iCCA samples and negatively correlated with TBX3 expression. Altogether, our findings suggest that overexpression of TBX3 suppresses CCA progression via repressing MAD2L1 expression.
2024
Overexpression of TBX3 suppresses tumorigenesis in experimental and human cholangiocarcinoma / Deng, Shanshan; Lu, Xinjun; Wang, Xue; Liang, Binyong; Xu, Hongwei; Yang, Doris; Cui, Guofei; Yonemura, Andrew; Paine, Honor; Zhou, Yi; Zhang, Yi; Simile, Maria Maddalena; Urigo, Francesco; Evert, Matthias; Calvisi, Diego F; Green, Benjamin L; Chen, Xin. - In: CELL DEATH & DISEASE. - ISSN 2041-4889. - 15:6(2024). [10.1038/s41419-024-06839-8]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/343049
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact